JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265144

Human ZDHHC6 (DHHC-6) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ZDHHC6 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2.

View Alternative Names

DHHC-6, FLJ21952, Probable palmitoyltransferase ZDHHC6, Transmembrane protein H4, ZDHC6_HUMAN, ZNF376, Zdhhc6, Zinc finger DHHC domain-containing protein 6, Zinc finger protein 376

1 Images
Sanger Sequencing - Human ZDHHC6 (DHHC-6) knockout HeLa cell line (AB265144)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZDHHC6 (DHHC-6) knockout HeLa cell line (AB265144)

Homozygous : 1 bp insertion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265144-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265144 Human ZDHHC6 (DHHC-6) knockout HeLa cell line", "number":"AB265144-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265144-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265144 Human ZDHHC6 (DHHC-6) knockout HeLa cell line", "number":"AB265144-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZDHHC6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DHHC-6 also known as ZDHHC6 is an enzyme that acts mechanically as a palmitoyltransferase attaching palmitate a fatty acid to the cysteine residues of substrate proteins which affects their localization and function. The enzyme weighs approximately 40 kDa. Expression of DHHC-6 occurs in various tissues notably in the liver and pancreas where its role seems significant due to its expression levels. This protein is a member of the zinc-dependent DHHC family and forms part of a larger palmitoylation machinery within cells.
Biological function summary

Palmitoylation modifies proteins to enable their proper folding and trafficking within cellular environments. DHHC-6 is part of various protein complexes that regulate these modifications imparting specific functional properties to target proteins. This regulation impacts cellular processes including signal transduction and protein sorting by ensuring proteins are correctly placed within membranes. Through this function DHHC-6 helps maintain normal cellular operations by stabilizing interactions between proteins and their lipid environments.

Pathways

Expression and activity of this enzyme are integral to processes involving protein acylation and membrane dynamics. DHHC-6 participates predominantly in the endoplasmic reticulum-associated degradation (ERAD) pathway facilitating the management and turnover of proteins within the endoplasmic reticulum. In this pathway DHHC-6 interacts closely with other proteins such as calnexin which is co-involved in ensuring protein folding and quality control occurs effectively.

Aberrant function of DHHC-6 has links to metabolic disorders and neurodegenerative diseases. Research implicates DHHC-6 in the progression of liver diseases particularly steatosis and related conditions partially due to disrupted protein palmitoylation roles in lipid metabolism. Additionally in neurodegenerative diseases such as Alzheimer's improper interaction with proteins like amyloid precursor protein (APP) may contribute to disease pathology highlighting the importance of precise DHHC-6 regulation in disease prevention and management.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com